Mental well-being, the theme of World No Tobacco Day 2027

The World Health Organization (WHO) announced on August 25, 2026, the theme for World No Tobacco Day 2027, to be held on May 31: «Mental well-being: protecting young minds from tobacco and nicotine»[1]. The campaign aims to document the links between tobacco or other nicotine product use, addiction and mental health in children and adolescents, and to challenge narratives that present these products as stress management tools.

An industrial discourse that is investing in the field of well-being

The WHO starts from the reality that children and young people are facing increasing pressures on their mental health. Furthermore, well-being, mental health, and self-care are playing a growing role in their concerns. It is precisely this space that the tobacco and nicotine industries are now seeking to invest in and occupy. They are positioning their products by associating them with notions of relaxation, stress reduction, and emotional well-being. More broadly, they are redirecting their corporate communications toward the "well-being" and "health" sectors. The World Health Organization emphasizes that this approach extends "decades of tobacco industry marketing aimed at associating tobacco and nicotine in general with relaxation, pleasure, and stress relief.".

This industrial strategy has consequences: young users frequently cite anxiety, stress, or depression as reasons for using e-cigarettes. However, as the WHO reminds us, exposure to nicotine damages the developing brain and leads to addiction as well as adverse effects on mental health. The withdrawal symptoms between uses cause "irritability, anxiety, and cravings, leading to repeated use solely to relieve these symptoms." The argument of stress relief is thus one of the most firmly entrenched perceived benefits among users, and yet one of the most contradicted by scientific data.

The relief felt corresponds to the removal of a need

Psychopharmacology documented this mechanism as early as the 1990s under the name "Nesbitt's paradox".«[2]. Between cigarettes, the drop in blood nicotine levels causes withdrawal symptoms in the dependent person: irritability, nervousness, tension, difficulty concentrating, and a depressed mood. The next cigarette makes these symptoms disappear and restores a state of normal functioning. The smoker interprets this return to normal as relaxation provided by tobacco, whereas it is actually the reversal of a state of craving that consumption itself created. In other words, the product sells the solution to a problem it generates, over a cycle of a few tens of minutes.

The Cochrane Review[3] A 2021 study dedicated to this topic compiled 102 observational studies involving over 169,500 participants, with follow-up periods ranging from six weeks to six years. Individuals who had quit smoking for at least six weeks experienced a reduction in depressive symptoms, anxiety, and stress, as well as improvements in positive emotions and psychological well-being, without any decline in their social lives.

A similar link was observed for vaping products.

Among adolescents, the association between nicotine use and mental health symptoms is also well-documented. Analysis of data from the 2021-2023 US National Youth Tobacco Survey, covering 60,072 middle and high school students, reports prevalence rates of depressive symptoms of 21.8% among non-users, 35.9% among exclusive e-cigarette users, and 43.4% among users who both vape and smoke. After adjustment, exclusive e-cigarette use is associated with an increased risk of depression, anxiety, and psychological distress.[4]. These cross-sectional data do not in themselves establish a sense of causality, but they directly contradict the positioning of vaping as a tool for stress management.

Added to these elements is the argument relating to the development of a young person recalled by the WHO: exposure to nicotine during adolescence, a period of brain maturation, affects brain development and promotes the rapid establishment of addiction.

Five campaign objectives and a call for public policies

The WHO assigns five objectives to the 2027 campaign: to raise awareness of the links between the use of tobacco or other nicotine products, addiction and the mental well-being of young people; to counter misleading narratives associating these products with stress management; to disseminate evidence-based prevention information to young people; to promote accessible and evidence-based cessation services; and to encourage governments to strengthen youth protection policies.

This theme extends that of the 2026 edition, which focused on protecting young people from tobacco and nicotine addiction. The WHO noted that 40 million children aged 13 to 15 use tobacco products worldwide. Dr. Etienne Krug, Director of the Department of Trade Determinants of Health at the WHO, described how manufacturers are "reinventing their business model" by promoting "flavored e-cigarettes, nicotine pouches, and other products designed to addict the next generation."«[5].

By focusing the 2027 edition on mental health, the WHO is opening a front that is still largely uncovered by national regulatory frameworks: that of implicit wellness claims made by the marketing of new nicotine products.

©Generation Without Tobacco

AE

[1] Press release, World No Tobacco Day 2027: Mental well-being, protecting young minds from tobacco and nicotine, WHO, published on August 25, 2026, accessed the same day.

[2] Parrott AC, Nesbitt's Paradox resolved? Stress and arousal modulation during cigarette smoking, Addiction, 93(1), 27-39, 1998.

[3] Taylor GMJ et al., Smoking cessation for improving mental health, Cochrane Database of Systematic Reviews, 2021

[4] Abdulhay N. et al., Mental health outcomes associated with electronic cigarette use, combustible tobacco use, and dual use among US adolescents: insights from the National Youth Tobacco Survey, PLOS Mental Health, 2(7), 2025

[5] Press release, The WHO urges governments to protect young people from addiction to tobacco and nicotine products., WHO, published on 29 May 2026, accessed on 26 August 2026.